Sucampo Pharma (SCMP) Tops Q3 EPS by 2c; Raises Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Sucampo Pharma (SCMP) Tops Q3 EPS by 2c; Raises Outlook

Sucampo Reports Third Quarter 2017 Financial Results

November 1, 2017 6:30 AM EDT

Company Increases 2017 Financial Guidance Based on Strong Performance Year to Date

Study Results for VTS-270 for Niemann-Pick Disease Type C1 Published in The Lancet

CPP-1X/sulindac Granted Fast-Track status by FDA for Adults with Familial Adenomatous Polyposis

FDA Accepted sNDA for AMITIZA for Pediatric Functional Constipation in Children 6-17 Years of Age, With Priority Review Designation

Company to Host Conference Call Today at 8:30 a.m. ET

... More